Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

The Jackson Labratory and The Johns Hopkins University Subscribe to Celera Database

Rockville, MD - June 11, 2001

Celera Genomics (NYSE: CRA), an Applera Corporation business, announced today that it has signed multi-year agreements with The Jackson Laboratory and The Johns Hopkins University, which will allow investigators from each of these institutions to access Celera’s database products through the Celera Discovery System (CDS)™. Financial terms of the agreements were not disclosed.

“Genomic information has the power to transform science and medicine. The challenge for researchers today is how to interpret and analyze vast amounts of data,” said J. Craig Venter, Ph.D., Celera’s president and chief scientific officer. “We are pleased that Johns Hopkins, a world leader in medicine and biomedical research, and Jackson Laboratory, the largest and most renowned mammalian genetic center, have chosen to use Celera’s accurate and annotated data, including the mouse genome, as well as our advanced tools and software. We believe CDS will help them better enable their researchers to meet this challenge and enhance their research programs.”

The Celera Discovery System is an integrated, web-based platform that enables users to leverage Celera’s computational tools, super-computing power, and the genomic and biological data to advance the discovery process for researchers worldwide.

About The Jackson Laboratory
The Jackson Laboratory is a unique nonprofit institution, leading the genetics revolution that is transforming medicine for the benefit of humanity. The National Cancer Institute of the National Institutes of Health has designated the Laboratory as a Cancer Center to perform basic research in cancer genetics. The world's largest mammalian genetics research facility, the Laboratory also serves a key role in the global scientific community as the provider of critical genetic resources and as a center for training present and future scientists. The Jackson Laboratory is home of the Mouse Genome Database, the integrated community database resource for the laboratory mouse, as well as other key information resources. Jackson Laboratory research has found applications in bone marrow transplantation; discovery and study of mutations that cause heart disease, obesity and diabetes; and development of mouse models for Down syndrome, epilepsy, and AIDS research.

About The Johns Hopkins University
The Johns Hopkins University, an international center for both undergraduate and graduate study and research, is a privately endowed, coeducational institution based in Baltimore, Maryland, with facilities throughout the Baltimore-Washington area and abroad. One of the smallest, by design, of America's great research universities, Johns Hopkins provides faculty and students of the highest caliber the freedom, resources, and challenge to excel in advanced study and original research. Year after year, through scores of international and national honors, Hopkins faculty are recognized as leaders in research, teaching, and patient care. Hopkins receives more U.S. government research and development support than any other academic institution in the country.

About Celera
Applera Corporation comprises two operating groups. The Celera Genomics Group, an integrated source of genomic and related medical information headquartered in Rockville, MD, is evolving to become a next generation diagnostic and therapeutic discovery company. Celera intends to leverage its industrialized approach to biology to develop platforms for enabling these new discoveries both for subscribers and for it’s own internal product development. The Applied Biosystems Group (NYSE:ABI) develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.4 billion during fiscal 2000. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the World Wide Web at, or by telephoning 800.762.6923.

Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.